VELA-1 and VELA-2 are two identical trials to evaluate the efficacy and safety of sonelokimab in adult participants with moderate to severe hidradenitis suppurativa (HS) and the…Read More
You might also be interested in reading Avalanche ‘bull trap’ risks pushing AVAX price down by 30% in February.